82.40 (-%)
As of Nov 01, 2024
Source:
Transmedics Group, Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the OCS to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide.
Country | United States |
Headquarters | andover, massachusetts |
Phone Number | 9785520900 |
Industry | manufacturing |
CEO | Waleed H. Hassanein, M.D. |
Website | www.transmedics.com |